Tony Perry

Tony Perry is a Professor in the Department of Life Sciences at the University of Bath, where he leads pioneering research in mammalian embryogenesis and the gamete-to-embryo transition. He is actively accepting doctoral students and has been principal investigator on multiple research projects funded by the MRC and BBSRC. His lab integrates embryological, molecular, and imaging techniques to study totipotency, epigenetic reprogramming, and genome editing in mouse models.

Research Interests:

• Embryology and developmental biology
• Mechanisms of cellular potency and totipotency
• Epigenetic reprogramming during fertilization
• Genome editing and transgenesis
• Nuclear transfer and cloning technologies
• Applications in infertility and regenerative medicine

His recent publications demonstrate groundbreaking work in reprogramming pathways, mechanical forces in early embryos, and switchable gene editing. These studies span disciplines including developmental biology, molecular genetics, and nanobiology, with strong translational implications for assisted reproductive technologies and mitochondrial disease prevention.

Scientific Recognition:

• Work featured in over 96 news outlets
• Publications widely shared on social media (X, Facebook)
• Referenced in patents and academic platforms like Mendeley and CiteULike
• Active conference participation

Advising and Grants:

Professor Perry supervises doctoral researchers and leads multiple funded projects, including New Perspectives on Imprinting Disease (MRC, 2022–2026) and Switchable Gene Drives (BBSRC, 2017–2021). His research is supported by major UK funding councils and involves interdisciplinary collaboration across biochemistry, genetics, and biomedical engineering. He also contributes to collaborative platforms such as high-throughput peptide synthesis.

Labs and Teams:

His research group at the University of Bath operates at the intersection of embryology and molecular innovation, utilizing advanced tools like piezo-actuated micromanipulation and sub-cellular transcriptomics. The team includes researchers like Masashi Asami and collaborates internationally. The lab’s website (egg2embryo.com) highlights their mission and key discoveries, including England’s first cloned mouse from an adult cell.